Financial Management Professionals Inc. Buys 91 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Financial Management Professionals Inc. raised its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 4.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,207 shares of the healthcare conglomerate’s stock after buying an additional 91 shares during the quarter. Financial Management Professionals Inc.’s holdings in UnitedHealth Group were worth $1,116,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of UNH. Raub Brock Capital Management LP boosted its stake in shares of UnitedHealth Group by 1.2% in the 4th quarter. Raub Brock Capital Management LP now owns 32,629 shares of the healthcare conglomerate’s stock valued at $16,506,000 after purchasing an additional 393 shares in the last quarter. Triangle Securities Wealth Management boosted its stake in shares of UnitedHealth Group by 18.6% in the 4th quarter. Triangle Securities Wealth Management now owns 4,887 shares of the healthcare conglomerate’s stock valued at $2,472,000 after purchasing an additional 767 shares in the last quarter. HB Wealth Management LLC boosted its stake in shares of UnitedHealth Group by 2.0% in the 4th quarter. HB Wealth Management LLC now owns 51,986 shares of the healthcare conglomerate’s stock valued at $26,298,000 after purchasing an additional 1,029 shares in the last quarter. Trust Co. of Vermont boosted its stake in shares of UnitedHealth Group by 9.1% in the 4th quarter. Trust Co. of Vermont now owns 38,993 shares of the healthcare conglomerate’s stock valued at $19,725,000 after purchasing an additional 3,268 shares in the last quarter. Finally, Sanibel Captiva Trust Company Inc. boosted its stake in shares of UnitedHealth Group by 3.4% in the 4th quarter. Sanibel Captiva Trust Company Inc. now owns 69,016 shares of the healthcare conglomerate’s stock valued at $34,912,000 after purchasing an additional 2,272 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Down 0.1 %

NYSE:UNH opened at $510.03 on Friday. The company has a market cap of $469.37 billion, a P/E ratio of 33.23, a price-to-earnings-growth ratio of 1.42 and a beta of 0.62. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The business has a 50 day moving average price of $549.37 and a two-hundred day moving average price of $562.73.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. During the same quarter last year, the firm posted $5.83 EPS. The company’s quarterly revenue was up 6.8% on a year-over-year basis. As a group, analysts expect that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were given a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.65%. The ex-dividend date was Monday, December 9th. UnitedHealth Group’s payout ratio is 54.72%.

Analysts Set New Price Targets

Several brokerages recently issued reports on UNH. Stephens upped their price target on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research report on Thursday, December 5th. HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target on the stock in a research report on Friday, January 10th. Cantor Fitzgerald reiterated an “overweight” rating and set a $700.00 price target on shares of UnitedHealth Group in a research report on Friday. Truist Financial cut their target price on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Finally, Piper Sandler lowered their price target on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research note on Thursday, January 2nd. Two research analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Buy” and a consensus target price of $627.74.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.